The place for all things HEMLIBRA® (emicizumab)
This website provides personalised information for healthcare professionals and patients about HEMLIBRA® (emicizumab). If you are a patient, you will need to log in using an access code that your doctor will provide.
© 2024 Roche Products Pty Limited
© 2024 Roche Products Pty Limited
ABN 70 000 132 865
Level 8, 30-34 Hickson Road, Sydney, NSW 2000, Australia
Medical Information: 1800 233 950
This website is not intended or designed for reporting adverse events (side effects). However if you would like to report an adverse event,
please contact Roche Australia Patient Safety department via email at australia.safety@roche.com
M-AU-00000191. Prepared November 2024
Roche Australia